Does Walnut Supplementation Have Favourable Effect Apolipoprotein A, B and Blood Pressure? A Systematic Review, Meta‐Analysis and Meta‐Evidence of Randomised Clinical Trials
Open Access
- 20 March 2026
- journal article
- review article
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (2) , e70171
Abstract
Backgrounds: Many randomised controlled trials (RCTs) have revealed the benefits of walnut on apolipoproteins and blood pressure, but the results are inconclusive. This meta‐analysis of RCTs aimed to assess the effects of walnut on Apolipoprotein B (ApoB), apolipoprotein A1 (ApoA1) and blood pressure. Methods: A systematic review of PubMed, Scopus, Web of Science, Cochrane and Embase databases was conducted, and the search time frame was from the establishment of the database up to January of 2025. A random effects model was applied to estimate weighted mean differences (WMDs) and 95% confidence intervals (CIs). Results: Twenty‐five RCTs comprising 26 intervention arms with 2155 patients were included. Walnut significantly decreased ApoB (WMD = −0.06; 95% CI: −0.10, −0.01, p = 0.002), but did not affect ApoA1 (WMD = −0.50; 95% CI: −1.34, 0.33, p = 0.249), systolic blood pressure (SBP) (WMD = −1.20; 95% CI: −4.02, 1.61, p = 0.401) and diastolic blood pressure (DBP) (WMD = −0.44; 95% CI: −2.55, 1.67, p = 0.682). Conclusion: Walnut intake was associated with reduced ApoB levels, with no significant effects observed on ApoA1, SBP, or DBP. Future research involving large‐scale, international RCTs is essential to validate its therapeutic potential further.Keywords
This publication has 53 references indexed in Scilit:
- Complementary medicine use in US adults with hypertension: A nationally representative surveyComplementary Therapies in Medicine, 2022
- Effects of walnut intake on blood pressure: A systematic review and meta‐analysis of randomized controlled trialsPhytotherapy Research, 2020
- Consumption of a defined, plant‐based diet reduces lipoprotein(a), inflammation, and other atherogenic lipoproteins and particles within 4 weeksClinical Cardiology, 2018
- Nut consumption has favorable effects on lipid profiles of Korean women with metabolic syndromeNutrition Research, 2014
- Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: A randomized controlled cross-over clinical trialMetabolism, 2014
- Nut Consumption and Blood Lipid LevelsArchives of internal medicine (1960), 2010
- Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trialBritish Journal of Nutrition, 2007
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Walnut-enriched diet increases the association of LDL from hypercholesterolemic men with human HepG2 cellsJournal of Lipid Research, 2001
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986